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Introduction
Urolithiasis, defined as the formation of urinary cal­
culi, represents one of the oldest known diseases, and 
nowadays it is the most common disease of the urinary 
tract (UT). Although globally occurrence and recurrence 
rates of kidney stones are constantly increasing, incidence 
can vary between different regions due to numerous spe­
cific risk factors1,2–6. Another public health problem as­
sociated with urolithiasis is a significant increase of its 
occurrence in the pediatric population7–9. Spivacow et al. 
showed an important role of metabolic abnormalities in 
children who suffer from urolithiasis10. The most common 
biochemical abnormality in their research was idiopathic 
hypercalciuria, and the second most common hypocitratu­
ria, followed by hyperoxaluria10. Risk factors associated 
with increased urolithiasis incidence in both adult and 
pediatric population are: increased sodium intake, de­
creased water and calcium intake, increased use of anti­
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A B S T R A C T
Urolithiasis is a disease characterized by formation of solid crystals within the urinary tract. Kidney stone formation 
is still not clear but it is mostly composed of calcium oxalate which can produce free radicals that are toxic to renal tubu-
lar cells. Oxidative stress is an important contributory mechanism in cell damage and is associated with a number of 
disorders. Several studies have shown antioxidative effects of caffeine, proposing its possible role in stopping the formation 
of calcium oxalate stones in urinary tract. Hence, the aim of this study was to evaluate the toxic effects of calcium  oxalate 
monohydrate crystals (COM) on renal epithelial cell line; Madin-Darby canine kidney cells subtype I (MDCK I) and 
 Epithelial-like pig kidney cell line (LLC-PK1), and to determine possible inhibition of COM that caused oxidative stress 
by antioxidant treatment with caffeine in different concentrations in a cell culture model of urolithiasis. 
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microbials, poor nutrition, sedentary lifestyle, and various 
pharmacological therapies (e.g. diuretics, anticonvulsants, 
corticosteroids), metabolic syndrome (decreased citrate 
excretion, increased urinary calcium and oxalate excre­
tion), along with global warming and higher environmen­
tal temperature10–12. Calcium stones, calcium oxalate and 
calcium phosphate are predominant kidney stones ac­
counting for 80% of all urinary calculi, and their  rate is 
higher than other types of kidney stones2. Other types of 
kidney stones are: cystine stones, uric acid stones, struvite 
or magnesium ammonium phosphate stones, and drug­
induced stones. Pathophysiological pathway in kidney 
stones formation consists of several events one leading to 
another: urinary supersaturation (e.g. hyperoxaluria), 
oxidative stress (OS), cell injury and rupture of cell mem­
brane, nucleation, crystal growth, crystal aggregation, 
crystal­cell interaction (considered as the crucial step in 
the formation of stone), crystal retention and, finally, stone 
formation2.
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Due to the above described pathophysiological mecha­
nism, the kidney stones formation is considered to be a 
complex process, especially because of numerous types of 
kidney stones, each with its specific characteristics. Nev­
ertheless, four most common models of stone formation 
have been identified: stones forming in inner medullary 
collecting ductus, stones forming in free solution in the 
renal collecting systems, formation of stones by attach­
ment to the renal papilla surface at sites of  Randall’s 
plaque, and formation of stones by fixation to the plugs 
protruding from the opening of the Bellini ducts13. Oxida­
tive stress, induced by calcium oxalate crystals, plays a 
significant role in calcium oxalate stone formation. Reac­
tive oxygen species (ROS) are produced during interac­
tions between renal cells and crystals, causing injury in 
renal cells14,15. This injury promotes sites for the crystal 
nucleation, aggregation, retention and stone development 
and represents a risk factor for the crystallization and 
crystals deposition in the kidney15. Accordingly, numerous 
studies showed a protective role of antioxidants catechin, 
vitamin E, L­arginine and selenium, against crystal and 
oxalate deposition­induced oxidative injury1,15.
Caffeine, also known as 1,3,7­trimethylxanthine, 
C8H10N4O2, is one of the most commonly consumed ac­
tive compounds worldwide. The main sources of dietary 
caffeine are coffee, soft drinks, tea, caffeinated beverages 
and chocolate products16. It exhibits pharmacologic and 
physiologic impact in renal, cardiovascular  and muscular 
system17. Caffeine is a natural alkaloid methylxanthine. 
It causes toxic or preventive effect in some physiological 
and pathological conditions, depending on numerous fac­
tors, for instance concomitant drug consumption, prior 
chronic exposure, genetic­enzymatic axes, and dose of caf­
feine. To date no evidence was found that usual daily dose 
of caffeine, such as 3 or 4 cups of coffee, increases the risk 
of nephropathy in healthy people18. On the other hand, it 
is well known that frequent caffeine consumption may 
enhance mood, cognitive function and alertness. The main 
mechanism of action of caffeine includes activation of ry­
anodine receptors and inhibition of phosphodiesterase 
enzyme and adenosine receptors, causing specific effects 
on organs19,20. It has been shown that consuming caffein­
ated beverages reduces the risk of developing kidney stone 
disease. On the other hand, its protective role and mecha­
nisms behind it are not fully elucidated and remain un­
known21. The aim of this study was to evaluate the effects 
of caffeine on formation of crystals and its antioxidative 
effects in an in vitro model of urolithiasis. 
Materials and Methods
Madine­Darby canine kidney cells subtype I (MDCKI) 
and LLC­PK1 were sub­cultivated in 10 cm dishes in Dul­
becco’s modified eagle medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS) and 1% antibiotic/an­
timycotic solution at 37 °C in a humidified atmosphere of 
5% CO2 in air. For the experiments of CaOX toxicity cells 
were cultivated in DMEM with antibiotic/antimycotic so­
lution but without FBS. These cells were used as an in 
vitro model of collector (MDCKI) and proximal (LLC­
PK1) tubules. These models have previously been estab­
lished and are widely used1.
To assess crystallization of CaOX crystals and protec­
tive effects of caffeine on it, cells were sub­cultivated in a 
6 well dish to 90% of confluency. CaOX crystals were pre­
pared according to previously established protocol by 
Peerapen at al.20 After achieving confluency, CaOX crys­
tals were added at a concentration of 8mM and caffeine in 
different concentrations (0,1, 1 and 10 mM). The cells were 
observed under light microscopy and crystals were count­
ed in three fields of view after one, three and twenty­four 
hours with an inverse light microscope. Counting was 
done in triplicates and the results are shown as an average 
with error bars. 
To determine total glutathione (GSH), cells were treat­
ed according to the previously described protocol, and af­
ter 24 hours of treatment with CaOX crystals and caffeine, 
cells were detached from the surface of the dish using 
rubber cell scraper. From these cells GSH was determined 
using a commercial kit according to manufacturer’s pro­
tocol (Gluthatione Assay Kit, Sigma­Aldrich, Saint Louis, 
MO, USA). Three controls were used; cells treated only 
with caffeine, cells treated only with CaOX crystals and 
untreated cells. Results are shown as a percentage accord­
ing to untreated cells.
Results
To show the effects of caffeine on formation of CaOx 
crystals in MDCKI and LLC­PK1 cell lines cells were cul­
tivated to 90% confluency. Furthermore, CaOx and caf­
feine were added and formed crystals were counted after 
1, 3 and 24 hours, according to previously described pro­
tocol. Results are graphically shown in Figure 1, as num­
ber of crystals counted in three fields of view. As a control, 
cells treated only with 8 mM CaOx crystals were used, 
and they showed a decreasing number of crystals in later 
counting (3 and 24 hours) compared to number of crystals 
after 1 hour, although a highest decrease of crystals was 
observed in MDCKI cell line after 24 hours. 
Comparing the number of crystals in MDCKI cell line 
concentrations of 0.1 mM and 1 mM of caffeine after 1 
hour showed no significant change of crystal numbers 
compared to control. Significantly less crystals were pres­
ent at all time points in cells treated with higher concen­
tration of caffeine (10 mM), and concentration of 1 mM 
caffeine showed less crystals after 3 and 24 hours com­
pared to the control. In LLC­PK1 cells treated with 1­ and 
10­mM caffeine significantly less crystals were measured 
at all time points but in the cells treated with lowest con­
centration of caffeine (0.1 mM) no significant difference 
in crystal numbers was observed (Figure 1). To evaluate 
redox tone in these cell lines GSH levels were measured 
in both cell lines after treatment of cells with CaOx crystals 
and different concentrations of caffeine. Three controls 
were used, untreated cells, cells treated only with CaOx 
and cells treated only with caffeine. There was no signifi­
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by certain types of fluids used to increase urine volume25. 
But, caffeine­rich beverages such as regular tea and coffee 
have been recognized as main sources of oxalate. More­
over, they may increase the urinary excretion of calcium, 
sodium, magnesium and chloride17. According to Massey’s 
research oral doses of coffee and tea can increase urinary 
calcium excretion26 while a study by Itoh et al. examined 
that green tea treatment reduced the urinary oxalate ex­
cretion and calcium oxalate deposit formation27. After 
 consummation, caffeine is rapidly absorbed from gastroin­
testinal tract and further distributed to kidneys and nu­
merous other tissues20,24. A recent in vitro study has dem­
onstrated a significant reduction in the adhesion of calcium 
oxalate (CaOx) crystals on renal tubular epithelial cells 
treated with caffeine20. Previous retrospective and pro­
spective studies have shown that caffeine has a diuretic 
effect, i.e. that it increases the excretion of calcium from 
the urine. After all, three large cohort studies also sug­
gested a preventive role for caffeine in kidney stone dis­
ease; a health care study, a health care study of nurses 
(NHS I), and another group of nurses (NHS II) with a 
total of more than 200,000 participants. The conclusion of 
these studies was that the consumption of caffeinated bev­
erages was associated with a lower risk (26–31%) of kidney 
stone disease28. A study by Massey et al. that examined 
the acute effect of caffeine on urine composition and the 
risk of developing kidney stones formed from calcium 
cant difference between cells treated only with caffeine to 
untreated cells, but cells treated only with CaOx showed 
a significant decrease of GSH level compared to untreated 
cells. In cells treated with caffeine and CaOx levels of GSH 
were higher than in cells treated only with CaOx. There 
was no significant difference of GSH levels between LLC­
PK1 cells treated with different concentrations of caffeine 
and CaOx, but in MDCKI cells concentration of 1 mM 
caffeine showed higher levels of GSH than in cells treated 
with other concentrations of caffeine and CaOx (Figure 2).
Discussion
Urolithiasis is a multifactorial disease and the most 
important factor is the supersaturation of urine with salts, 
including oxalates, which cause damage to epithelial 
cells22. The most frequent form of kidney stone is calcium 
oxalate which can produce free radicals and its develop­
ment is a complex process of a few physicochemical events 
that include: nucleation, expansion, aggregation and su­
persaturation2. Some studies have shown that caffeine 
induced inhibitory effect on fluid reabsorption along prox­
imal renal tubules causes diuresis and natriuresis23. Its 
effects have been studied in several kidney diseases, but 
its role in kidney stone disease seems to be insufficiently 
elucidated24. Occurrence of kidney stones may be decreased 
Fig. 2. Effects of caffeine on GSH levels in two cell lines, MDCKI and LLC-PK1. + indicates addition of CaOx or caffeine, - indicates 
no caffeine or CaOX was added, 0,1, 1 and 10 mM indicates amount of caffeine added.
Fig. 1. Number of formed crystals in two cell lines, MDCKI and LLC-PK1. Crystals were counted 1, 3 and 24 hours, after addition of 
8 mM CaOX and different concentrations of caffeine. + indicates addition of CaOx, - indicates no caffeine was added, 0,1, 1 and 10 
mM indicates amount of caffeine added.
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 oxalate confirmed that caffeine consumption may reduce 
the risk of calcium oxalate stones29,30.
In the current study, caffeine was shown to have a ben­
eficial effect in reducing the level of oxidative cell damage 
compared to cells in which there was no caffeine treatment 
by the level of total glutathione concentration. The expres­
sion of total glutathione (tGSH) was increased in samples 
of cells (MDCKI and LLCPK1) treated with caffeine in 
proportion to its concentration, thus indicating the exist­
ing positive antioxidant activity due to caffeine adminis­
tration. The highest concentration of caffeine had the 
greatest protective effect in the MDCKI and LLCPK1 
cells model. The protective effects of caffeine on kidney 
stone formation of COM were evaluated and the results 
showed that caffeine decreased the number of crystals. In 
LLC­PK1 cell line a smaller number of crystals depending 
on time exposure for the same concentrations of caffeine 
in comparison to MDCKI was observed. In our study a 
proportional decrease in the number of calcium oxalate 
crystals was recognized with an increase in the added 
concentration of caffeine as also shown by Ferraro et al.19 
where a significant association was found between caf­
feine intake and the risk of developing kidney stones. In 
the study by Peerapen et al. it has been shown that caf­
feine did not affect crystal growth and cristallization of 
calcium oxalate monohidrate (COM), but it has significant 
role in reducing  intracellular calcium storage by increas­
ing calcium­mediated mechanisms of secretion and excre­
tion20. Such as annexin A1 translocation from apical mem­
brane into cytoplasm. This causes decreased COM 
crystal­binding capacity of renal tubular epithelial cells. 
Therefore, it is considered protective mechanism of caf­
feine against COM kidney stones formation17. Dietary 
agents play an important role in the formation of urinary 
calculus, and a change in diet can reduce the risk of stone 
recurrence. Therefore, new strategies with therapeutic ap­
plications of antioxidants to decrease stone recurrence 
after Shockwawe lithotripsy (SWL) and Ureterorenoscopy 
(URS) should be considered.
Conclusion
The obtained results suggest that caffeine can lower 
crystallization causing a significant reduction in the num­
ber of crystalline calcium oxalate and has a positive effect 
by lowering oxidative stress in our in vitro models of uro­
lithiasis. It would be interesting for future research to 
measure caffeine effect on crystal size. More studies are 
needed to further evaluate the role of caffeine in the for­
mation of kidney stones. 
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UTJECAJ KOFEINA NA KRISTALIZACIJU I SMANJENJE OKSIDATIVNOGA STRESA U IN VITRO 
MODELU UROLITIJAZE
S A Ž E T A K
Urolitijaza je bolest koju karakterizira stvaranje čvrstih kristala unutar mokraćnoga sustava. Mehanizam stvaran­
ja bubrežnih kamenaca još je uvijek nejasan, a uglavnom se sastoji od kalcijevoga oksalata koji može proizvesti slobodne 
radikale toksične za bubrežne tubularne stanice. Oksidativni stres važan je mehanizam koji doprinosi oštećenju stani­
ca i povezan je s nizom poremećaja. Nekoliko je studija pokazalo antioksidativne učinke kofeina, sugerirajući njegovu 
moguću ulogu u zaustavljanju stvaranja kalcijevih oksalatnih kamenaca u mokraćnim putovima. Stoga je cilj ovoga 
istraživanja bio procijeniti toksični učinak kristala kalcijevog oksalata monohidrata (COM) na staničnu liniju bubrežnoga 
epitela, Madin-Darbyjeve pseće stanice bubrega podtipa I (MDCK I) i epitelne stanice bubrega svinje (LLC-PK1), te 
utvrditi moguće inhibicije COM-a (uzroka oksidativnoga stresa) antioksidativnim tretmanom kofeinom u različitim 
koncentracijama na modelu stanične kulture urolitijaze.
